{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:43:07Z","timestamp":1787625787211,"version":"build-2736575974"},"reference-count":21,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.5551\/jat.65290","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T22:08:35Z","timestamp":1753481315000},"page":"89-98","source":"Crossref","is-referenced-by-count":3,"title":["Long-term Clinical Outcomes after Endovascular Treatment by Aortoiliac Artery Stent Implantation"],"prefix":"10.5551","volume":"33","author":[{"given":"Akiko","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Cardiology, Sendai Kousei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Saiseikai Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terutoshi","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Matsuyama Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Soga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the REAL-AI Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral arterial disease in 2000 and 2010: a systematic review and analysis. Lancet, 2013; 382: 1329-1340","DOI":"10.1016\/S0140-6736(13)61249-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation, 2004; 110: 738-743","DOI":"10.1161\/01.CIR.0000137913.26087.F0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med, 1992; 326: 381-386","DOI":"10.1056\/NEJM199202063260605"},{"key":"4","unstructured":"4) Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 2018; 39: 763-816"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation, 2017; 135: e726-e779","DOI":"10.1161\/CIR.0000000000000502"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg, 2007; 33: S1-S75","DOI":"10.1016\/j.ejvs.2006.09.024"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Miura T, Soga Y, Miyashita Y, et al. Five-year prognosis after endovascular therapy in claudicant patients with iliofemoral artery disease. J Endovasc Ther, 2014; 21: 381-388","DOI":"10.1583\/13-4618R.1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Soga Y, Iida O, Yamauchi Y, et al. REAL-AI investigators. Contemporary outcomes after endovascular treatment for aorto-iliac artery disease. Circ J, 2012; 76: 2697-2704","DOI":"10.1253\/circj.CJ-12-0492"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Iida O, Soga Y, Takahara M, et al. Perioperative complications after aorto-iliac stenting: associated factors and impact on follow-up cardiovascular prognosis. Eur J Vasc Endovasc Surg ,2014; 47: 131-138","DOI":"10.1016\/j.ejvs.2013.09.024"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Suzuki K, Iida O, Soga Y, et al. Long\u2010term results of the S.M.A.R.T. control stent for superficial femoral artery lesions, J\u2010SMART registry. Circ J, 2011; 75: 939\u2010944","DOI":"10.1253\/circj.CJ-10-1029"},{"key":"11","unstructured":"11) Soga Y, Takahara M, Iida O, et al. Ten-year clinical follow-up following bare-nitinol stent implantation for femoropopliteal artery disease. J Ateroscler Thromb, 2021; 28: 63225"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) de Vries SO, Hunink MG. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg, 1997; 26: 558-569","DOI":"10.1016\/S0741-5214(97)70053-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Michele P, Francesco S, Bassini S, et al. The impact of female sex on the outcomes of endovascular treatment for iliac lesions. J Vasc Surg, 2020; 71; 2039-2047","DOI":"10.1016\/j.jvs.2019.08.271"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Carlos H, Scott L, Freeman MB, Goldman MH. External iliac and common iliac artery angioplasty and stenting in men and women. J Vasc Surg, 2001; 34; 440-446","DOI":"10.1067\/mva.2001.117148"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Iida O, Takahara M, Yamauchi Y, et al. Impact of hospital volume on clinical outcomes after aortoiliac stenting in patients with peripheral artery disease. J Ateroscler Thromb, 2020; 27; 516-523","DOI":"10.5551\/jat.51631"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hisako K, Hiroyoshi K, Araki Y, et al. 15-year patency and life expectancy after primary stenting guided by intravascular ultrasound for iliac artery lesions in peripheral arterial disease. JACC Cardiovasc Interv, 2015; 8: 1893-1901","DOI":"10.1016\/j.jcin.2015.08.020"},{"key":"17","unstructured":"17) Solene M, Aymeric C, Lambert O, et al. Urea levels and cardiovascular disease in patients with chronic kidney disease. Nephrol Dial Transplant, 2022; gfac045"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 2003; 108: 2154-2169","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Iida O, Takahara M, Soga Y, et al. Three-year outcomes of surgical versus endovascular revascularization for critical limb ischemia: the SPINACH study (surgical reconstruction versus peripheral intervention in patients with critical limb ischemia). Circ Cardiovasc Interv, 2017; 10: e005531","DOI":"10.1161\/CIRCINTERVENTIONS.117.005531"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) de Cort BA, Salemans PB, Fritschy WM, et al. Long-term outcome for covered endovascular reconstruction of aortic bifurcation for aortoiliac disease: a single-center experience. J Endovasc Ther, 2021; 28: 906-913","DOI":"10.1177\/15266028211028210"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Anand SS, Hiatt W, Dyal L, et al. Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials. Eur J Preventive Cardiol, 2022; 29: e181-e189","DOI":"10.1093\/eurjpc\/zwab128"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/1\/33_65290\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:18:12Z","timestamp":1767413892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/1\/33_65290\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65290","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"65290"}}